{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:51:49Z","timestamp":1787237509129,"version":"build-2736575974"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,16]]},"DOI":"10.7759\/cureus.64680","type":"journal-article","created":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T17:30:35Z","timestamp":1721151035000},"source":"Crossref","is-referenced-by-count":4,"title":["Paradoxical Eczema Associated With Interleukin-17A Inhibitor Use in a Patient With Generalized Pustular Psoriasis Accompanied by Asthma"],"prefix":"10.7759","author":[{"given":"Kazuki","family":"Yatsuzuka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamoto","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16246","article-title":"Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review","volume":"34","author":"Al-Janabi A","year":"2020","unstructured":"Al-Janabi A, Foulkes AC, Mason K, Smith CH, Griffiths CE, Warren RB. Phenotypic switch to eczema in patients receiving biologics for plaque psoriasis: a systematic review. J Eur Acad Dermatol Venereol. 2020, 34:1440-8. 10.1111\/jdv.16246","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4846","article-title":"Risk of paradoxical eczema in patients receiving biologics for psoriasis","volume":"160","author":"Al-Janabi A","year":"2024","unstructured":"Al-Janabi A, Alabas OA, Yiu ZZ, et al.. Risk of paradoxical eczema in patients receiving biologics for psoriasis. JAMA Dermatol. 2024, 160:71-9. 10.1001\/jamadermatol.2023.4846","journal-title":"JAMA Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2020.06.064","article-title":"Mixed profile of cytokines in paradoxical eczematous eruptions associated with anti-IL-17 therapy","volume":"8","author":"Chicharro P","year":"2020","unstructured":"Chicharro P, Rodr\u00edguez-Jim\u00e9nez P, De la Fuente H, Fraga-Fern\u00e1ndez J, Cibrian D, S\u00e1nchez-Madrid F, Daud\u00e9n E. Mixed profile of cytokines in paradoxical eczematous eruptions associated with anti-IL-17 therapy. J Allergy Clin Immunol Pract. 2020, 8:3619-21.e1. 10.1016\/j.jaip.2020.06.064","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.07.011","article-title":"Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics","volume":"152","author":"Al-Janabi A","year":"2023","unstructured":"Al-Janabi A, Martin P, Khan AR, et al.. Integrated proteomics and genomics analysis of paradoxical eczema in psoriasis patients treated with biologics. J Allergy Clin Immunol. 2023, 152:1237-46. 10.1016\/j.jaci.2023.07.011","journal-title":"J Allergy Clin Immunol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16047","article-title":"Recurrence of secukinumab-induced eczematous eruptions after guselkumab treatment for pustular psoriasis","volume":"48","author":"Miyagawa F","year":"2021","unstructured":"Miyagawa F, Fukuda K, Mori A, Ogawa K, Asada H. Recurrence of secukinumab-induced eczematous eruptions after guselkumab treatment for pustular psoriasis. J Dermatol. 2021, 48:498-9. 10.1111\/1346-8138.16047","journal-title":"J Dermatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.15511","article-title":"Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis","volume":"47","author":"Kawasaki Y","year":"2020","unstructured":"Kawasaki Y, Kamata M, Shimizu T, et al.. Thymus and activation-regulated chemokine (TARC) in patients with psoriasis: Increased serum TARC levels in patients with generalized pustular psoriasis. J Dermatol. 2020, 47:1149-56. 10.1111\/1346-8138.15511","journal-title":"J Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.06.008","article-title":"Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan","volume":"86","author":"Miyachi H","year":"2022","unstructured":"Miyachi H, Konishi T, Kumazawa R, et al.. Treatments and outcomes of generalized pustular psoriasis: a cohort of 1516 patients in a nationwide inpatient database in Japan. J Am Acad Dermatol. 2022, 86:1266-74. 10.1016\/j.jaad.2021.06.008","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/ced.15052","article-title":"Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?","volume":"47","author":"Megna M","year":"2022","unstructured":"Megna M, Caiazzo G, Parisi M, et al.. Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?. Clin Exp Dermatol. 2022, 47:918-25. 10.1111\/ced.15052","journal-title":"Clin Exp Dermatol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12988","article-title":"The crucial role of IL-22 and its receptor in thymus and activation regulated chemokine production and T-cell migration by house dust mite extract","volume":"25","author":"Jang M","year":"2016","unstructured":"Jang M, Kim H, Kim Y, et al.. The crucial role of IL-22 and its receptor in thymus and activation regulated chemokine production and T-cell migration by house dust mite extract. Exp Dermatol. 2016, 25:598-603. 10.1111\/exd.12988","journal-title":"Exp Dermatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2023-223850","article-title":"Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story","volume":"83","author":"Bonelli M","year":"2024","unstructured":"Bonelli M, Kerschbaumer A, Kastrati K, et al.. Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story. Ann Rheum Dis. 2024, 83:139-60. 10.1136\/ard-2023-223850","journal-title":"Ann Rheum Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/exd.14958","article-title":"Development of IL-17A inhibitor-induced atopic dermatitis-like rash in psoriasis patients: insights into immune shift","volume":"33","author":"Li Q","year":"2024","unstructured":"Li Q, Li X, Li W, et al.. Development of IL-17A inhibitor-induced atopic dermatitis-like rash in psoriasis patients: insights into immune shift. Exp Dermatol. 2024, 33:14958. 10.1111\/exd.14958","journal-title":"Exp Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/273395-paradoxical-eczema-associated-with-interleukin-17a-inhibitor-use-in-a-patient-with-generalized-pustular-psoriasis-accompanied-by-asthma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T17:30:38Z","timestamp":1721151038000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/273395-paradoxical-eczema-associated-with-interleukin-17a-inhibitor-use-in-a-patient-with-generalized-pustular-psoriasis-accompanied-by-asthma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.64680","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}